Thoracic Oncology Group of Australasia

Podcasts

Listen to TOGA’s podcast on the latest treatments and topics in lung cancer and mesothelioma. Hosted by a variety of experts to bring together a multidisciplinary and collaborative perspective.

TOGA Podcast Series

A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
This episode is hosted by: A/Prof Steven Kao, Prof Wendy Cooper, and Prof Ben Solomon
This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.
This episode is hosted by: Dr Rebecca Tay, Professor Nick Pavlakis, and Dr Deme Karikios.
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Vanessa Brunelli, Fiorina Gibbons, Melissa Laan and Associate Professor Henry Marshall
Thoracic Oncology Group of Australasia podcast, hosted by: Professor Shalini Vinod, Assoc Professor Mei-Ling Yap and Dr Clare Bajraszewski
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Michael Franco, Professor Catherine Jones and Dr Diane Pascoe
Thoracic Oncology Group of Australasia podcast, hosted by: A/Prof Melissa Moore, A/Prof Tom John and A/Prof Adnan Nagrial
Thoracic Oncology Group of Australasia podcast, hosted by: A/Prof Emily Stone and joined by A/Prof Gavin Wright, A/Prof Nicole Rankin and A/Prof Annette McWilliams
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Jazmin Eckhaus and joined by A/Prof Emily Stone, A/Prof Melissa Moore and Professor Catherine Granger.
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Tom John and joined by Professor Charles Swanton, Associate Professor Venessa Chin and Dr Tracy
Thoracic Oncology Group of Australasia podcast, hosted by: A/Professor Tim Clay and joined by Professor Lucy Morgan, A/Professor Phillip Antippa and also Dr Qurrat van
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Chee Lee joined by Dr Tristan Barnes and Dr Alex Davis.
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Jenny Lee joined by Professor Nick Pavlakis and Lisa Briggs.
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Prunella Blinman joined by Assistant Professor Narjust Florez, Professor Lorraine Chantrill and Dr Rebecca Tay.
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Paul Mitchell, joined by Dr Fiona Hegi-Johnson and Dr Dasantha Jayamanne.
In this episode, Dr Malinda Itchins is joined by Professor Stephen Fox, and Professor Michael Millward to discuss NGS panels in lung cancer.
A/Prof Gavin Wright discusses Lung Cancer Screening Program and its impact on patient care in Australia. He is joined by A/Prof Emily Stone, A/Prof Nicole
Prof Shankar Siva, A/Prof Rachel Wong and Prof Drew Moghanaki discuss what defines inoperable NSCLC, patient selection and how to manage the toxicities associated with
A/Prof Melissa Moore is joined by Dr Katharine See and Dr Naveed Alam to discuss and review the findings and implications for NSCLC patients.
Dr Deme Karikios, Dr Wanda Cui and A/Prof Chris Karapetis discuss the advances in oncogene-driven lung cancer and what this means for trial design, patients
In this episode, we discuss smoking cessation in the face of smoking-related stigma and nihilism. Dr Henry Marshall, Prof Christine Paul and Dr Matt Steliga
A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner to positively impact the future
A/Prof Rachel Roberts-Thomson, A/Prof Venessa Chin and Angeline Low discuss improving outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer.
In this episode, Respiratory Physicians Prof Emily Stone , Prof Rob Stirling and Prof Fraser Brims discuss the need for funding for a national quality
In this episode, we discuss ALK therapy choices and considerations when treating ALK NSCLC. Dr Malinda is joined by A/Prof Steven Kao and Lisa Briggs
In recognising Lung Cancer Awareness 2021, A/Prof Melissa Moore, Briony Scott, Prof Suzanne Chambers and Prof Stewart Dunn,discuss the importance of treating lung cancer patients
Briony Scott discusses the stigma often associated with a diagnosis of lung cancer with Danielle and Terri – both diagnosed with lung cancer and managing
In this episode, Prof Nick Pavlakis and Prof Stephen Fox discuss Next-generation sequencing (NGS) based tumour comprehensive genomic profiling (CGP) that detects a wide range
Prof Stephen Clarke and A/Prof Kellie Charles, the team that discovered that cancer-related inflammation altered chemotherapy pharmacokinetics, toxicity and survival, come together to discuss the
In this episode we discuss how delays in diagnosis are one of the main factors associated with reduced survival rates and how we can improve
In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.
A/Prof Melissa Moore and Prof Lucy Morgan discuss the increase in lung cancer diagnoses for young women who have never smoked before.
In this episode, Prof Emily Stone and Prof Kwun Fong, both long time advocates and researchers in early screening discuss the challenges of implementing a
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer